Roche Pharma India signs MoU with NIPER in Raebareli
March 19, 2026 | Thursday | News
To create a collaborative industry-academia ecosystem that nurtures talent
Roche Pharma India has signed a Memorandum of Understanding (MoU) with National Institute of Pharmaceutical Education and Research (NIPER) Raebareli to foster academic–industry collaboration and strengthen pharmaceutical education and research in India.
The MoU was signed at the Department of Pharmaceuticals (DoP) in the presence of Manoj Joshi, IAS, Secretary, DoP.
Roche and NIPER Raebareli will work together to bridge the gap between academic learning and real-world industry practices, equipping students and faculty with insights into evolving pharmaceutical and regulatory landscapes.
As part of the MoU, engagements like: A certificate programme in regulatory affairs for students and industry professionals, Guest lecture series by industry experts on emerging trends in AI for pharmaceutical research, drug development and healthcare innovation, scholarship-cum-industry exposure opportunities to students at NIPER Rae Bareli through Roche’s LEAP programme, and faculty immersion programs are planned.
Officials present at the event emphasised the importance of such collaborations strengthening India’s position as a global hub for biopharmaceutical innovation. Such initiatives will help build a skilled workforce, encourage research in advanced pharmaceutical technologies for a strong and resilient healthcare system.
In February 2026, Roche Pharma had signed an MoU with NIPER Mohali to partner in the areas of curriculum design and development, student mentorship, setting up professors of practice, scholarship-cum-industry exposure opportunities to students at NIPER Mohali through Roche’s LEAP programme, and delivery of industry-relevant short-term courses aimed at making the students of NIPER-Mohali as industry-ready professionals.
